Calumet Specialty Products Partners CLMT · NASDAQ
$56.42 -2.30% (-$1.33)
Summary
25 / 100 · Bulios Score
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 86.3 years of operating profit.
- The share price is above the Bulios Fair Price.
- Revenue fell by 4.1% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 13% a year over 5 years. Over the last 3 years it fell by 4.1% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $136.8M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 15.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 4
- Hold 18
- Sell 1
Today's price within the analysts' price targets
The average target of $55.67 is 1.3% below today's price. 17% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Specialty Products and Solutions 64%
- Montana/Renewables 29%
- Performance Brands 7.5%
By region
The company reports no revenue by region.
Specialty Products and Solutions brings in 64% of revenue. Montana/Renewables grew fastest, by 11% a year.
Segments in detail